| アイテムタイプ |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2025-06-26 |
| タイトル |
|
|
タイトル |
Incidence of Coronavirus Disease 2019‐Associated Pulmonary Aspergillosis and Specialist Involvement in Its Diagnosis in Japan: A Nationwide Survey and Literature Review |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
aspergillus |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
COVID-19 |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
COVID-19 associated pulmonary aspergillosis |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
epidemiology |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
incidence |
| キーワード |
|
|
言語 |
en |
|
主題Scheme |
Other |
|
主題 |
specialis |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Ito, Yuya
Takazono, Takahiro
Namie, Hotaka
Tashiro, Masato
Kakeya, Hiroshi
Miyazaki, Yoshitsugu
Mukae, Hiroshi
Mikamo, Hiroshige
Fukuda, Tomoo
Shibuya, Kazutoshi
Izumikawa, Koichi
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
Background: Coronavirus disease 2019 (COVID-19)-associated pulmonary aspergillosis (CAPA) has been reported worldwide. However, studies in Japan are limited, and no study has evaluated the relationship between the incidence of CAPA and specialist involvement in its diagnosis. Objectives: We aimed to obtain new epidemiological data on CAPA in Japan and evaluate the relationship between the incidence of CAPA and specialist involvement in its diagnosis. Methods: A survey was conducted among chief physicians at 760 training hospitals with at least 100 beds and accredited by the Japanese Respiratory Society or the Japanese Association for Infectious Diseases. Critical patients with COVID-19 diagnosed with CAPA between 1 January 2020 and 31 August 2023 were analysed. A literature review was conducted to evaluate the correlations between the incidence of CAPA and galactomannan (GM) testing and positivity rates. Results: Responses were obtained from 221 of the 760 hospitals (29.1%). The incidence of CAPA was 0.67% (69/10,276). Hospitals with patients with CAPA had significantly more pulmonologists and infectious disease specialists than those without patients with CAPA. A strong positive correlation was observed between the incidence of CAPA and the number of pulmonologists per critical patient with COVID-19 (r = 0.824, p < 0.001). The literature review showed that bronchoalveolar lavage fluid GM testing rate was a strong positive correlation with the incidence of CAPA (r = 0.527, p = 0.014). Conclusions: For the diagnosis of CAPA, its recognition by specialists primarily involved in managing critical patients with COVID-19 seems essential. |
|
言語 |
en |
| 書誌情報 |
en : Mycoses
巻 68,
号 6,
p. art. no. e70077,
発行日 2025-06-09
|
| 出版者 |
|
|
出版者 |
John Wiley and Sons Inc |
|
言語 |
en |
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
0933-7407 |
| DOI |
|
|
関連タイプ |
isIdenticalTo |
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.1111/myc.70077 |
| 権利 |
|
|
権利情報 |
© 2025 Wiley-VCH GmbH. Published by John Wiley & Sons Ltd. This is the peer reviewed version of the following article: Mycoses, 68(6), art. no. e70077; 2025, which has been published in final form at https://doi.org/10.1111/myc.70077. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. |
|
言語 |
en |
| 著者版フラグ |
|
|
出版タイプ |
AM |
|
出版タイプResource |
http://purl.org/coar/version/c_ab4af688f83e57aa |
| 引用 |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Mycoses, 68(6), art. no. e70077; 2025 |
|
言語 |
en |